XML 57 R43.htm IDEA: XBRL DOCUMENT v3.19.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Principles of Consolidation thru Goodwill (Details)
12 Months Ended
Dec. 31, 2018
USD ($)
item
Dec. 31, 2017
USD ($)
Dec. 31, 2016
USD ($)
Nov. 30, 2018
Jan. 02, 2018
USD ($)
Feb. 28, 2017
Principles of Consolidation            
Percentage of interest in a non-consolidated entity 22.00%     4.70%   22.00%
Reclassifications            
Shipping and handling costs, reclassified from SG&A to Cost of sales   $ 55,426,000 $ 45,795,000      
Cost of nursing support services, reclassified from SG&A to cost of sales   19,108,000 13,447,000      
Concentrations of Risk            
Noninterest-bearing cash balances insurance coverage per depositor at each financial institution $ 250          
Receivables            
Receivables, net 326,602,000 332,091,000     $ 325,608,000  
Trade receivables and allowance for doubtful accounts            
Trade receivables collateral amount $ 0          
Trade receivables terms after sale of product or performance of service 30 days          
Beginning balance $ (22,050,000) (15,257,000) (8,123,000)      
Charged to expense 8,660,000 9,424,000 9,534,000      
Write-offs, net of recoveries 5,368,000 2,631,000 2,400,000      
Ending balance $ (25,342,000) (22,050,000) $ (15,257,000)      
Inventories            
Maximum period before expiration within which Inventory is returnable and fully refundable 6 months          
Goodwill            
Number of reporting units | item 3          
Software and Software Development Costs            
Capitalized Software for Internal Use, net            
Useful life 3 years          
Trade receivables            
Receivables            
Receivables, net $ 299,407,000 317,004,000        
Allowance for trade receivables (25,342,000) (22,050,000)        
Rebate receivables            
Receivables            
Receivables, net 22,375,000 12,847,000        
Other receivables            
Receivables            
Receivables, net $ 4,820,000 $ 2,240,000        
Celgene            
Concentrations of Risk            
Percentage of total drug purchases 17.00% 17.00% 13.00%      
Minimum purchase obligation $ 0          
Pharmacyclics            
Concentrations of Risk            
Percentage of total drug purchases 17.00% 14.00% 10.00%      
Minimum purchase obligation $ 0          
AmerisourceBergen            
Concentrations of Risk            
Percentage of total drug purchases 28.00% 41.00% 49.00%      
Not wholly owned subsidiary            
Principles of Consolidation            
Percentage of ownership interest in subsidiary that the entity has the ability to control 51.00%